Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : World Heart Corp - WHRT and TSE/WHT -- Ignore unavailable to you. Want to Upgrade?

To: Dan Hamilton who wrote (95)	7/28/1998 8:18:00 AM
From: the Chief	Respond to of 500

Hi Dan. "I don't know about you, but I'd rather have my heart in my chest, not in my stomach". Yep, I think I would like to be able to tell the difference between having a stomach ache or having a heart attack!!<ggg> the Chief

To: Dan Hamilton who wrote (95)	7/28/1998 12:15:00 PM
From: the Chief	Respond to of 500

Wall Street Journal says profit projected for 2001 World Heart Corp WHT Shares issued 12,243,000 Jul 27 close $12.10 Tue 28 Jul 98 In the News The Globe and Mail reports in a Wall Street Journal story in its Tuesday edition that with a fresh spin on a familiar technology, an Ottawa startup has set its sights on the potentially huge market for artificial hearts. Reporter John Urquhart says that ambitiously named World Heart, the Ottawa company has yet to earn a dime for its shareholders. Its management, however, is projecting its first profit, of about $13-million (U.S.) in 2001, when the company expects its first full year of sales. Backed by a team of medical researchers and high-tech entrepreneurs, World Heart is one of many companies, small and large, developing a new generation of artificial heart devices for the millions of people suffering from various kinds of heart failure. World Heart's product, the HeartSaver, is drawing attention from the medical community, in part because of the way it is powered and its compact size. World Heart is conducting tests on animals and aims to start human trials in late 1999. (c) Copyright 1998 Canjex Publishing Ltd. canada-stockwatch.com